← Evidence map

ArticleDiabetology & metabolic syndrome2022

The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy.

Ying Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35351189